Literature DB >> 2575042

Review of alpha adrenoceptor function in the eye.

D McAuliffe-Curtin1, C Buckley.   

Abstract

The location and function of alpha adrenoceptors in the eye are reviewed with emphasis on pharmacological agents and their role in the management of chronic simple glaucoma.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2575042     DOI： 10.1038/eye.1989.71

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


  6 in total

1.  Ocular responses in healthy subjects to topical bunazosin 0.3%--an alpha 1-adrenoceptor antagonist.

Authors:  D R Trew; L A Wright; S E Smith
Journal:  Br J Ophthalmol       Date:  1991-07       Impact factor: 4.638

2.  GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure.

Authors:  Tatsuo Itakura; Andrew Webster; Shravan K Chintala; Yuchen Wang; Jose M Gonzalez; J C Tan; Janice A Vranka; Ted Acott; Cheryl Mae Craft; Maria E Sibug Saber; Shinwu Jeong; W Daniel Stamer; Kirill A Martemyanov; M Elizabeth Fini
Journal:  J Ocul Pharmacol Ther       Date:  2019-03-18       Impact factor: 2.671

3.  Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial.

Authors:  Jay S Pepose; Paul J Hartman; Harvey B DuBiner; Marc A Abrams; Robert J Smyth-Medina; Sayoko E Moroi; Alan R Meyer; Mina P Sooch; Reda M Jaber; Konstantinos Charizanis; Seth A Klapman; Arin T Amin; Jonah E Yousif; Eliot S Lazar; Paul M Karpecki; Charles B Slonim; Marguerite B McDonald
Journal:  Clin Ophthalmol       Date:  2021-01-08

4.  Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.

Authors:  David L Wirta; Michael S Korenfeld; Shane Foster; Robert Smyth-Medina; Jason Bacharach; Shane R Kannarr; Mark J Jaros; Charles B Slonim
Journal:  Clin Ophthalmol       Date:  2021-10-08

5.  Effect of Topical Dexmedetomidine (0.0055%) on Intraocular Pressure in Healthy Eyes: A Randomized Controlled Trial.

Authors:  Henry Fakhoury; Youssef Abdelmassih; Sylvain El-Khoury; Mazen Amro; Karen Zaarour; Carole Cherfan; Karim Tomey; Ziad Khoueir
Journal:  J Curr Glaucoma Pract       Date:  2021 May-Aug

Review 6.  Targeted Drug Delivery Systems for the Treatment of Glaucoma: Most Advanced Systems Review.

Authors:  Olga Cegielska; Paweł Sajkiewicz
Journal:  Polymers (Basel)       Date:  2019-10-24       Impact factor: 4.329
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.